Skip to main content

Closed

IBIO: iBio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+77.8% / yr

Operating margin-7985.3%

ROIC-30.0%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-167.5×

Current ratio11.88×

iBio, Inc.

IBIONASDAQ Capital Market·USD·Closed

iBio, Inc.

IBIONASDAQ·USD·Closed

$1.40

+0.72%

$1.40

+$0.01 (0.72%)

52W Range

26thpctl

Volume

0.75×avg

Mkt Cap

22.11MUSD

P/E

-2.4TTM

Div Yield

–ann

52W Range

26thpctl

Volume

0.75×avg

Market Cap

22.11MUSD

P/E Ratio

-2.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings